Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)

Autor: Warren, Richard B., French, Lars E., Blauvelt, Andrew, Langley, Richard G., Egeberg, Alexander, Mrowietz, Ulrich, Hunter, Hamish J.A., Gooderham, Melinda, Soerensen, Per, Andres, Philippe, Sommer, Morten O.A., Carlsson, Anna, Kjøller, Kim D., Strober, Bruce E.
Zdroj: In Journal of the American Academy of Dermatology March 2024 90(3):494-503
Databáze: ScienceDirect
Externí odkaz: